We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Cincinnati Financial
CINF
$26.4B
| $89.4K | ﹤0.01% |
+757
| New | +$88.8K |
|
1577
IDEX
IEX
$16.4B
| $89.1K | ﹤0.01% |
443
+17
| +4% | +$3.71K |
|
1578
Occidental Petroleum
OXY
$60.3B
| $88.4K | ﹤0.01% |
1,403
-2,096
| -60% | -$134K |
|
1579
DTE Energy
DTE
$27.2B
| $86.8K | ﹤0.01% |
782
-129
| -14% | -$14.4K |
|
1580
Raymond James Financial
RJF
$32.2B
| $86.4K | ﹤0.01% |
699
-104
| -13% | -$12.8K |
|
1581
Boston Properties
BXP
$10.3B
| $86.2K | ﹤0.01% |
1,400
-614
| -30% | -$37.5K |
|
1582
Rollins
ROL
$16.5B
| $86.2K | ﹤0.01% |
1,766
+249
| +16% | +$11.5K |
|
1583
Nordson
NDSN
$17.4B
| $81.2K | ﹤0.01% |
350
-312
| -47% | -$78.7K |
|
1584
Seaboard Corp
SEB
$4.15B
| $79K | ﹤0.01% |
25
-1
| -4% | -$3.22K |
|
1585
Atmos Energy
ATO
$27.6B
| $75.9K | ﹤0.01% |
651
-4,948
| -88% | -$577K |
|
1586
Seagate
STX
$179B
| $73.4K | ﹤0.01% |
711
+8
| +1% | +$747 |
|
|
CTRA
1587
DELISTED
Coterra Energy
CTRA
| $72.2K | ﹤0.01% |
2,707
-18,053
| -87% | -$500K |
|
1588
Avis
CAR
$4.19B
| $69.4K | ﹤0.01% |
664
-35
| -5% | -$3.92K |
|
1589
Corpay
CPAY
$26.6B
| $67.4K | ﹤0.01% |
253
+246
| +3,514% | +$69.6K |
|
1590
TriCo Bancshares
TCBK
$1.72B
| $66.6K | ﹤0.01% |
1,683
-228
| -12% | -$8.24K |
|
|
RJET
1591
Republic Airways Holdings
RJET
$821M
| $66.3K | ﹤0.01% |
2,584
| – | – |
|
|
MRX
1592
Marex Group Limited Ordinary Shares
MRX
$5.09B
| $65.6K | ﹤0.01% |
+3,280
| New | +$64.5K |
|
1593
Bumble
BMBL
$399M
| $64.7K | ﹤0.01% |
6,157
-34,296
| -85% | -$374K |
|
1594
Under Armour Class C
UA
$2.13B
| $64.4K | ﹤0.01% |
9,860
-898
| -8% | -$5.94K |
|
|
BTAI
1595
DELISTED
BioXcel Therapeutics
BTAI
| $64.3K | ﹤0.01% |
3,141
+147
| +5% | +$4.92K |
|
1596
Northeast Bank
NBN
$1.16B
| $64.1K | ﹤0.01% |
1,053
| – | – |
|
1597
Rogers Corp
ROG
$2.31B
| $63.2K | ﹤0.01% |
524
-10,356
| -95% | -$1.21M |
|
1598
Regency Centers
REG
$13.5B
| $62.7K | ﹤0.01% |
1,008
+563
| +127% | +$33.7K |
|
1599
Lincoln National
LNC
$8.35B
| $61.8K | ﹤0.01% |
1,986
-201
| -9% | -$6.08K |
|
1600
American Eagle Outfitters
AEO
$2.55B
| $60.5K | ﹤0.01% |
3,032
-44
| -1% | -$1.01K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.